Evolution of Public Health Human Papillomavirus Immunization Programs in Canada

Background: Since 2007, all Canadian provinces and territories have had a publicly funded program for vaccination against human papillomavirus (HPV) infection. The objective of this study was to describe the evolution of these vaccination programs. Methods: This was a targeted literature review of p...

Full description

Bibliographic Details
Published in:Current Oncology
Main Authors: Goyette, Alexandra, Yen, Glorian P., Racovitan, Voica, Bhangu, Parambir, Kothari, Smita, Franco, Eduardo L.
Format: Text
Language:English
Published: MDPI 2021
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985769/
http://www.ncbi.nlm.nih.gov/pubmed/33617515
https://doi.org/10.3390/curroncol28010097
id ftpubmed:oai:pubmedcentral.nih.gov:7985769
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:7985769 2023-05-15T17:22:41+02:00 Evolution of Public Health Human Papillomavirus Immunization Programs in Canada Goyette, Alexandra Yen, Glorian P. Racovitan, Voica Bhangu, Parambir Kothari, Smita Franco, Eduardo L. 2021-02-22 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985769/ http://www.ncbi.nlm.nih.gov/pubmed/33617515 https://doi.org/10.3390/curroncol28010097 en eng MDPI http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985769/ http://www.ncbi.nlm.nih.gov/pubmed/33617515 http://dx.doi.org/10.3390/curroncol28010097 © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). CC-BY Curr Oncol Article Text 2021 ftpubmed https://doi.org/10.3390/curroncol28010097 2021-03-28T01:46:59Z Background: Since 2007, all Canadian provinces and territories have had a publicly funded program for vaccination against human papillomavirus (HPV) infection. The objective of this study was to describe the evolution of these vaccination programs. Methods: This was a targeted literature review of public HPV vaccination programs and vaccination coverage rates, based on information provided by jurisdictional public health authorities. Results: HPV vaccination of schoolgirls began in school years 2007/08 to 2010/11 with three doses of the quadrivalent HPV vaccine in all provinces except Quebec, which started with two doses. By 2018/19, all jurisdictions were vaccinating with two doses of the nonavalent vaccine in both girls and boys, except Quebec, which used a mixed vaccination schedule with one dose of the nonavalent and one dose of the bivalent vaccines. Public HPV vaccination programs in most provinces include after-school catch-up vaccination. Immunocompromised or other high-risk individuals are eligible for the HPV public vaccination program in most provinces, but policies vary by jurisdiction. In 2017/18, vaccination coverage rates in provincial HPV school-based programs varied from 62% in Ontario to 86% in Prince Edward Island in girls and from 58% in Ontario to 86% in Prince Edward Island in boys. Conclusions: Since their introduction, Canadian school-based HPV public vaccination programs have evolved from a three-dose to a two-dose schedule, from a quadrivalent to a nonavalent vaccine, and from a girls-only to a gender-neutral policy. Vaccination coverage rates have varied markedly and only Prince Edward Island and Newfoundland/Labrador have maintained rates exceeding 80%. Text Newfoundland Prince Edward Island PubMed Central (PMC) Canada Newfoundland Current Oncology 28 1 991 1007
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Article
spellingShingle Article
Goyette, Alexandra
Yen, Glorian P.
Racovitan, Voica
Bhangu, Parambir
Kothari, Smita
Franco, Eduardo L.
Evolution of Public Health Human Papillomavirus Immunization Programs in Canada
topic_facet Article
description Background: Since 2007, all Canadian provinces and territories have had a publicly funded program for vaccination against human papillomavirus (HPV) infection. The objective of this study was to describe the evolution of these vaccination programs. Methods: This was a targeted literature review of public HPV vaccination programs and vaccination coverage rates, based on information provided by jurisdictional public health authorities. Results: HPV vaccination of schoolgirls began in school years 2007/08 to 2010/11 with three doses of the quadrivalent HPV vaccine in all provinces except Quebec, which started with two doses. By 2018/19, all jurisdictions were vaccinating with two doses of the nonavalent vaccine in both girls and boys, except Quebec, which used a mixed vaccination schedule with one dose of the nonavalent and one dose of the bivalent vaccines. Public HPV vaccination programs in most provinces include after-school catch-up vaccination. Immunocompromised or other high-risk individuals are eligible for the HPV public vaccination program in most provinces, but policies vary by jurisdiction. In 2017/18, vaccination coverage rates in provincial HPV school-based programs varied from 62% in Ontario to 86% in Prince Edward Island in girls and from 58% in Ontario to 86% in Prince Edward Island in boys. Conclusions: Since their introduction, Canadian school-based HPV public vaccination programs have evolved from a three-dose to a two-dose schedule, from a quadrivalent to a nonavalent vaccine, and from a girls-only to a gender-neutral policy. Vaccination coverage rates have varied markedly and only Prince Edward Island and Newfoundland/Labrador have maintained rates exceeding 80%.
format Text
author Goyette, Alexandra
Yen, Glorian P.
Racovitan, Voica
Bhangu, Parambir
Kothari, Smita
Franco, Eduardo L.
author_facet Goyette, Alexandra
Yen, Glorian P.
Racovitan, Voica
Bhangu, Parambir
Kothari, Smita
Franco, Eduardo L.
author_sort Goyette, Alexandra
title Evolution of Public Health Human Papillomavirus Immunization Programs in Canada
title_short Evolution of Public Health Human Papillomavirus Immunization Programs in Canada
title_full Evolution of Public Health Human Papillomavirus Immunization Programs in Canada
title_fullStr Evolution of Public Health Human Papillomavirus Immunization Programs in Canada
title_full_unstemmed Evolution of Public Health Human Papillomavirus Immunization Programs in Canada
title_sort evolution of public health human papillomavirus immunization programs in canada
publisher MDPI
publishDate 2021
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985769/
http://www.ncbi.nlm.nih.gov/pubmed/33617515
https://doi.org/10.3390/curroncol28010097
geographic Canada
Newfoundland
geographic_facet Canada
Newfoundland
genre Newfoundland
Prince Edward Island
genre_facet Newfoundland
Prince Edward Island
op_source Curr Oncol
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985769/
http://www.ncbi.nlm.nih.gov/pubmed/33617515
http://dx.doi.org/10.3390/curroncol28010097
op_rights © 2021 by the authors.
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
op_rightsnorm CC-BY
op_doi https://doi.org/10.3390/curroncol28010097
container_title Current Oncology
container_volume 28
container_issue 1
container_start_page 991
op_container_end_page 1007
_version_ 1766109482866180096